Literature DB >> 11869550

[Isolation and characterization of human prostate cancer cell subclones with different metastatic potential].

Y Liu1, J Zheng, W Fang, J You, J Wang, X Cui, B Wu.   

Abstract

OBJECTIVE: To isolate and characterize cancer cell subclones with different metastatic potential from human metastatic prostate cancer cell line (PC-3M).
METHODS: Using limited dilution, in vitro growth, Matrigel invasion assay, soft agar cloning and in vivo tumorigenicity and spontaneous metastasis assay in nude mice, were isolated and characterized four subclones with different metastatic potential.
RESULTS: Four subclones derived from PC-3M were 1E8, 2E7, 2B6, 2B4. Each subclone exhibited a different metastatic potential when inoculated into nude mice. Among these subclones, 1E8 expressed as the highly metastatic phenotype, with 100% metastasis frequency 5 weeks after subcutaneous inoculation into nude mice, whereas 2B4 was not metastatic. In vitro 1E8 was found to be the most highly invasive cell line in Matrigel invasive assay (98 +/- 24) and had the most clones in soft agar cloning assay (265 +/- 39) while 2B4 was found to have the least invasive abilities (12 +/- 4) and the least clones (137 +/- 14).
CONCLUSION: Successful establishment of these subclones with different metastatic potential may be valuable for further study on the molecular mechanisms of cancer metastasis and cloning of cancer metastasis-related genes.

Entities:  

Mesh:

Year:  1999        PMID: 11869550

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


  8 in total

1.  Screening of differently expressed genes in human prostate cancer cell lines with different metastasis potentials.

Authors:  Anping Song; Guoning Liao; Mingfu Wu; Yunping Lu; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

2.  LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity.

Authors:  Fang Mei; Jiangfeng You; Beiying Liu; Mengxue Zhang; Jiangying Liu; Bo Zhang; Fei Pei
Journal:  Tumour Biol       Date:  2014-12-12

3.  Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression.

Authors:  Liangsheng Fan; Hongyan Wang; Xi Xia; Yumei Rao; Xiangyi Ma; Ding Ma; Peng Wu; Gang Chen
Journal:  Oncol Lett       Date:  2012-09-21       Impact factor: 2.967

4.  ARMC8α promotes proliferation and invasion of non-small cell lung cancer cells by activating the canonical Wnt signaling pathway.

Authors:  Chengyao Xie; Guiyang Jiang; Chuifeng Fan; Xiupeng Zhang; Yong Zhang; Yuan Miao; Xuyong Lin; Junhua Wu; Liang Wang; Yang Liu; Juanhan Yu; Lianhe Yang; Di Zhang; Ke Xu; Enhua Wang
Journal:  Tumour Biol       Date:  2014-06-04

5.  Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.

Authors:  X Zeng; Z Hu; Z Wang; J Tao; T Lu; C Yang; B Lee; Z Ye
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-01-14       Impact factor: 5.554

6.  Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.

Authors:  Jing Chen; Shunwang Cao; Bo Situ; Juan Zhong; Yanwei Hu; Shufen Li; Jinlan Huang; Jiasen Xu; Shiyang Wu; Jinduan Lin; Qianwen Zhao; Zhen Cai; Lei Zheng; Qian Wang
Journal:  J Exp Clin Cancer Res       Date:  2018-06-28

7.  Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP.

Authors:  Hui Wang; Kai Li; Yu Mei; Xuemei Huang; Zhenglin Li; Qingzhu Yang; Huanjie Yang
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-26       Impact factor: 8.886

8.  Proteomic analysis of human prostate cancer PC-3M-1E8 cells and PC-3M-2B4 cells of same origin but with different metastatic potential.

Authors:  Shujiang Zhang; Chengcheng Zheng; Shunheng Yao; Zhonghui Wang; Li Xu; Rongfu Yang; Xiang Meng; Jianhui Wu; Li Zhou; Zuyue Sun
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.